Full Length Research Paper
References
AFRO (2004). WHO Africa. Region Leprosy Elimination Programme National Managers' Meeting, Harare, June 29-July1, 2004. | ||||
Al-Qubati Y, Al- Dobai BM (1999). Review of leprosy control in Yemen. Internl. J. Lep. 67(2):150-153. | ||||
Anonymous (1992). New Drug Therapy-WHO Coordinate Trials. Horizons, 16:16-17. | ||||
Berthe D, Haimanot RT, Tedla T, Taddesse T (1990). Epidemiological pattern of leprosy in Ethiopaia: A review of the control programmes, Lep. Rev. 61:258-266. | ||||
Bhgagoliwal A, Chandra J, Mishra RS (1979). Some observations on the default among leprosy patients. Lep India 51:96-102. | ||||
Blake LA, West BC, Lary CH, Todd JR (1987). Environmental nonhuman sources of leprosy [review]. Rev. Infect. Dis. 9(3):562-77. http://dx.doi.org/10.1093/clinids/9.3.562 PMid:3299637 |
||||
Brightmer MI (1990). New cases of leprosy in the Cross River Region, Nigeria. Lep Rev. 61:273-281. PMid:2215061 |
||||
Bryeceson A, Pfaltzgraff ER (1990). Leprosy. 3rd Ed. Edinburgh: Churchhill Livingstone, New York, pp 1-230. | ||||
Cap JA (1981). The epidemiological situation in Africa. Lep. Rev. 52 (Suppl): 53-60. PMid:6978450 |
||||
Cochcrane RG (1947). A practical text-book of leprosy. Oxford University press. London. Pages 1-16. | ||||
Danielsen DC, Boeck CW (1848). Traile de la spedalskher on elepantiasis des Grees. JB Bailliere, Paris. Pages 1-3. | ||||
Daumerie D (1991). Leprosy in the WHO African Region. World Health Stat Quart 44:16-22. PMid:2068820 |
||||
Diallo AS, Bide L, Tiendrebeogo A, Nsom MC, Keita S, Bah A (2002). Role of combined monitoring and updating registers in eliminating leprosy in Africa: Guinea and Cameroon experience. Presentation, Yaounde, Cameroon. | ||||
Fine PE, Smith PG (1996). Vaccination against leprosy - the view from 1996 [editorial]. Lepr. Rev. 67(4):249-52. PMid:9033195 |
||||
Fine PE (1982). Leprosy: the epidemiology of a slow bacterium [review]. Epid Rev. 4:161-88. | ||||
Hertroijs ARA (1974). Study of some factors affecting the attendance of patients in a leprosy control scheme. Int. J. Lep. 42:119-127. | ||||
Hunter JM, Thomas MO (1984). Hypothesis of leprosy, tuberculosis and urbanization in Africa. Soc. Sci. Med. 19 (1): 27-57. http://dx.doi.org/10.1016/0277-9536(84)90134-5 |
||||
International Leprosy Association Technical Forum (2002). Report. Lepr. Rev. 73:S1-S62. | ||||
ILEP(1998). Medical Bulletin. Advice from the ILEP Medico-Social commission. Operational guidelines for the introduction of new MDT for the treatment of leprosy. ILEP; 14:1-5. | ||||
International Leprosy Congress, Havana (1948). Report of the Committee on classification and nomenclature. Int. J. Lep. 16:201-208. | ||||
Kazda J, Irgens M, Kolk AHJ (1990). Acid fast bacilli found in sphagnum vegetation of coastal Norway containing Mycobacterium leprae specific phenolic glycolipid-1. Internl. J. Lep. 58:353-357. | ||||
Klatser PR, van Beers S, Madjid B, Day R, de Wit MY (1993). Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic. J. Clin. Microbiol. 31(11):2947-51. PMid:8263180 PMCid:PMC266167 |
||||
Kyriakis KP, Kontoch-istopoulos GJ, Panteleas DN (1994). Current profile of active leprosy in Greece: A five-year retrospective study (1988-1992). Internl. J. Lep. 62(4):547-551. | ||||
Meima A (2002). The impact of multidrug therapy on trends in transmission. Working paper for the Scientific Working Group meeting on Leprosy Research, convened by the Special Programme for Research and Training in Tropical Diseases, Geneva, 26-28 February 2002; Pages 1-5. | ||||
Noordeen SK (1995). Elimination of leprosy as a public health problem. Why the optimum is justified. Internl. J. Lep. 63:559-566. | ||||
Noordeen SK (1985). The epidemiology of leprosy. In: Leprosy, Hastings RC(Ed), Churchhill Livingstone, produced by Longman Group(FE) Ltd. Hongkong. Pages 15-30. | ||||
Nsagha DS (2002). Epidemiology and Community Perception of Leprosy in Boyo, Menchum and Mezam Divisions of Cameroon. PhD Thesis, University of Ibadan, Ibadan, Nigeria. pp. 1-394. | ||||
Nsagha DS, Bamgboye EA, Oyediran ABOO (2009). Operational barriers to the implementation of multi-drug therapy and leprosy elimination in Cameroon. Indian J. Dermatol. Venereol. Leprol. 75(5):469-475. http://dx.doi.org/10.4103/0378-6323.55389 PMid:19736425 |
||||
Nsagha DS, Bissek ACZK, Nsagha SM, Njunda AL, Assob JCN, Tabah EN, Bamgboye EA, Oyediran ABOO, Nde PF, Njamnshi AK (2011a). Social stigma as an epidemiological determinant for leprosy elimination in Cameroon. J. Public Health Afri. 2(e10):38-44. | ||||
Nsagha DS, Njunda AL, Bissek ACZK, Assob JCN, Nsagha SM, Kamga HL, Tabah EN, Bamgboye EA, Oyediran ABOO, Obama MTO, Njamnshi AK (2011b). Rehabilitation as an epidemiological determinant for leprosy elimination in Cameroon. J. Public Health Afri. (In press). http://dx.doi.org/10.4081/jphia.2011.e10 |
||||
Nsom MC (1999). Point de la situation de la lèpre au Cameroun. Dossier de presse. 46eme Journée Mondiale des lépreux. Dimanche 31 Janvier; pp. 1-2. | ||||
Ong AKY, Frankel RI, Maruyama MH (1999). Cluster of leprosy cases in Kona, Hawaii: Impact of the compact of free association. 67(1):13-18. | ||||
Provincial Delegation of Public Health Documentation (2008). Leprosy control unit, Bamenda, North West Province, Cameroon, pp 1-6. | ||||
Provincial Delegation of Public Health documentation (1996). Leprosy control unit, Bamenda: North West Province, Cameroon. pp 1-12. | ||||
Reich CV (1987). Leprosy: cause, transmission, and a new theory of pathogenesis. Rev. Infect. Dis. 9(3):590-4. http://dx.doi.org/10.1093/clinids/9.3.590 PMid:3299638 |
||||
Ridley DS, Jopling WH (1966). Classification of leprosy according to immunity: A five-group system. Internat J. Lep. 34:255-273. | ||||
The Star (1997). Facts about Hansen's disease.; 56 (3):16. | ||||
van Beers SM, Hatta M, Klatser PR (1999). Patient contact is the major determinant in incident leprosy: implications for future control. Internl. J. Lepr. Other Mycobact. Dis. 67(2):119-28. PMid:10472363 |
||||
Waaldijk K (1989). An evaluation of 35 years of leprosy control in Northern Nigeria as demonstrated in the original pilot project, Katsina. Lep. Rev. 60:59-61. | ||||
WHO (1998). Trends in leprosy detection. Wkly Epid Rec. 23: 169-176. | ||||
WHO (1991). Progress in leprosy control through multi-drug therapy. World Health Stat, 44:28. | ||||
WHO (1995). Progress towards the elimination of leprosy as a public health problem. Wkly Epid Rec, 26:185-188. | ||||
WHO (1982). Study Group. Chemotherapy of leprosy for control programmes. WHO Technical Report Series, 1982; No. 675. |
Copyright © 2023 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0